Palah Biswas On Unique Identity No1.mpg

Unique Identity No2

Please send the LINK to your Addresslist and send me every update, event, development,documents and FEEDBACK . just mail to palashbiswaskl@gmail.com

Website templates

Zia clarifies his timing of declaration of independence

what mujib said

Jyothi Basu Is Dead

Unflinching Left firm on nuke deal

Jyoti Basu's Address on the Lok Sabha Elections 2009

Basu expresses shock over poll debacle

Jyoti Basu: The Pragmatist

Dr.BR Ambedkar

Memories of Another day

Memories of Another day
While my Parents Pulin Babu and basanti Devi were living

"The Day India Burned"--A Documentary On Partition Part-1/9

Partition

Partition of India - refugees displaced by the partition

Thursday, August 12, 2010

Fwd: [MedicalConspiracies] Vitamin B3 as a Novel Approach to Treat Fungal Infections



---------- Forwarded message ----------
From: Grannie's <granniefox@gmail.com>
Date: Thu, Aug 12, 2010 at 9:04 AM
Subject: [MedicalConspiracies] Vitamin B3 as a Novel Approach to Treat Fungal Infections
To: "1 MedicalConspiracies@googlegro" <MedicalConspiracies@googlegroups.com>, "1 Paranormal_Research@yahoogrou" <Paranormal_Research@yahoogroups.com>




-------- Original Message --------
Subject: [Health_and_Healing] Vitamin B3 as a Novel Approach to Treat Fungal Infections
Date: Wed, 11 Aug 2010 17:56:56 -0000
From: rpa20523 <rpautrey2@yahoo.com>
To: Health_and_Healing@yahoogroups.com


www.sciencedaily.comhttp://www.sciencedaily.com/releases/2010/07/100708141617.htmhttp://www.sciencedaily.com/releases/2010/07/100708141617.htm   Vitamin B3 as a Novel Approach to Treat Fungal Infections    ScienceDaily (Aug. 10, 2010)   A team of scientists from the Institute for Research in Immunology and Cancer (IRIC) of the University of Montreal have identified vitamin B3 as a potential antifungal treatment.  Led by IRIC Principal Investigators Martine Raymond, Alain Verreault and Pierre Thibault, in collaboration with Alaka Mullick, from the Biotechnology Research Institute of the National Research Council Canada, the study is the subject of a recent article in Nature Medicine.  Infections by the yeast Candida albicans represent a significant public health problem and a common complication in immunodeficient individuals such as AIDS patients, cancer patients undergoing chemotherapy and recipients of organ transplants. While some treatments are available, their efficacy can be compromised by the emergence of drug-resistant strains.  The current study shows that a C. albicans enzyme, known as Hst3, is essential to the growth and survival of the yeast. Researchers found that genetic or pharmacological inhibition of Hst3 with nicotinamide, a form of vitamin B3, strongly reduced C. albicans virulence in a mouse model. Both normal and drug-resistant strains of C. albicans were susceptible to nicotinamide. In addition, nicotinamide prevented the growth of other pathogenic Candida species and Aspergillus fumigatus (another human pathogen), thus demonstrating the broad antifungal properties of nicotinamide.  "There is an urgent need to develop new therapies to kill C. albicans because it is one of the leading causes of hospital-acquired infections and is associated with high mortality rates," explains Martine Raymond, who is also a professor at the University of Montreal Department of Biochemistry. "Although many issues remain to be investigated, the results of our study are very exciting and they constitute an important first step in the development of new therapeutic agents to treat fungal infections without major side effects for patients."  Martine Raymond is Principal Investigator in the Yeast Molecular Biology Laboratory. Alain Verreault is Principal Investigator in the Chromosome Biogenesis Laboratory. Pierre Thibault is Principal Investigator in the Proteomics and Bioanalytical Mass Spectrometry Laboratory. The research received funding from the Canadian Institutes for Health Research and the National Science and Engineering Research Council of Canada.   The above story is reprinted (with editorial adaptations by ScienceDaily staff) from materials provided by University of Montreal, via EurekAlert!, a service of AAAS. Journal Reference:  Hugo Wurtele, Sarah Tsao, Guylaine Lépine, Alaka Mullick, Jessy Tremblay, Paul Drogaris, Eun-Hye Lee, Pierre Thibault, Alain Verreault, Martine Raymond. Modulation of histone H3 lysine 56 acetylation as an antifungal therapeutic strategy. Nature Medicine, 2010; 16 (7): 774 DOI: 10.1038/nm.2175      «¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»§«¤»¥«¤»§«¤»¥«¤»

§ Health_and_Healing - PULSE ON 21st CENTURY ALTERNATIVE MEDICINE & WORLD NEWS

http://groups.yahoo.com/group/Health_and_HealingHealth_and_Healing-subscribe@yahoogroups.com

DETOX WITH ALL NATURAL PURE GREEN CALCIUM BENTONITE CLAY USED INTERNAL/EXTERNAL http://clayadvantage.com/http://WWW.THEOPENLINE.ORG

ENERGY HEALING TECHNIQUE FOR CHRONIC PAIN, PTSD & OTHER ISSUES THAT TROUBLE YOU. http://vibrantenergy.webs.com
Subscribe send email to: THE OPEN LINE NEWSPAPER, HEALTH NEWS, SPIRITUAL, ENVIRONMENT, ETC.
--
To subscribe: MedicalConspiracies-subscribe@googlegroups.com
 
DETOX WITH All NATURAL PURE GREEN CALCIUM BENTONITE CLAY USED INTERNAL/EXTERNAL http://clayadvantage.com/
 
Information here in is for educational purpose only; it may be news related, purely
speculation or SOMEONE’S OPINION. Consult with a qualified MD before deciding on any course of treatment, especially for serious or life-threatening illnesses.
By becoming a member of this group you AGREE to hold this group its members, list owners, moderators and affiliates harmless of any liability for any direct, or indirect consequential, incidental, damage incurred.
 
http://www.law.cornell.edu/uscode/17/107.shtml
In accordance with Title 17 U.S.C. Section 107,
**COPYRIGHT NOTICE



--
Palash Biswas
Pl Read:
http://nandigramunited-banga.blogspot.com/

No comments:

Post a Comment